Research & Literature

Respiratory and otolaryngologic manifestations of giant cell arteritis.

Imran TF, Helfgott S

Clinical and experimental rheumatology 2015; (33(2 Suppl 89)):S-164-70.

Using temporal artery biopsy to diagnose giant cell arteritis in a patient with bilateral arm ischemia.

Glaser J, Sharim R, Birnbaum B, et al.

International journal of surgery case reports 2015; (13()):95-8.

Level of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study.

Emamifar A, Gildberg-Mortensen R, Andreas Just S, et al.

International journal of rheumatology 2015; (2015()):783709 doi:10.1155/2015/783709.

[SHOULD PATIENTS WITH GIANT CELL ARTERITIS BE TESTED FOR AORTIC ANEURYSMS?].

Milchert M, Brzosko M

Annales Academiae Medicae Stetinensis 2014; (60(2)):37-9.

[Pathogenesis of large vessel vasculitis].

Samson M, Bonnotte B

La Revue de medecine interne 2016; (37(4)):264-73.

Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.

Mansalis K

FP essentials 2016; (440()):16-22.

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis.

Evans J, Steel L, Borg F, Dasgupta B

RMD open 2016; (2(1)):e000137 doi:10.1136/rmdopen-2015-000137.

Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.

Grossman C, Barshack I, Koren-Morag N, et al.

Clinical rheumatology 2016; (35(7)):1817-22 doi:10.1007/s10067-016-3221-1.

Temporal arteritis with erythrocyte sedimentation rate <50 mm/h: a clinical reminder.

Cheema MR, Ismaeel SM

Clinical interventions in aging 2016; (11()):185-8 doi:10.2147/CIA.S40919.

Aortitis due to giant cell arteritis and psoriatic arthritis: An uncommon association.

García-Cezón de la Cruz MDP, Almodóvar R, García Pérez J, et al.

Reumatologia clinica 2017; (13(4)):230-232 doi:10.1016/j.reuma.2016.03.016.

Predictors of Dissection in Aortic Aneurysms From Giant Cell Arteritis.

Kermani TA, Warrington KJ, Crowson CS, et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2016; (22(4)):184-7 doi:10.1097/RHU.0000000000000381.

Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.

Buttgereit F, Dejaco C, Matteson EL, Dasgupta B

JAMA 2016; (315(22)):2442-58 doi:10.1001/jama.2016.5444.

Extracranial giant cell arteritis: A narrative review.

Lensen KD, Voskuyl AE, Comans EF, et al.

The Netherlands journal of medicine 2016; (74(5)):182-92.

Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis.

Broder MS, Sarsour K, Chang E, et al.

Seminars in arthritis and rheumatism 2016; (46(2)):246-252 doi:10.1016/j.semarthrit.2016.05.009.

Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update.

Nesher G, Breuer GS

Rambam Maimonides medical journal 2016; (7(4)) doi:10.5041/RMMJ.10262.

Widespread headache as the first clinical manifestation of giant cell arteritis in patients affected by polymyalgia rheumatica.

Manzo C

Reumatologia 2016; (54(5)):236-238 doi:10.5114/reum.2016.63663.

Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.

Wilson JC, Sarsour K, Collinson N, et al.

Seminars in arthritis and rheumatism 2017; (46(6)):819-827 doi:10.1016/j.semarthrit.2016.11.006.

An unusual case of aortic rupture after deployment of a bare stent in the treatment of aortic dissection in a patient with giant-cell arteritis.

Rynio P, Kazimierczak A, Gutowski P, Cnotliwy M

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques 2017; (12(2)):194-198 doi:10.5114/wiitm.2017.67677.

Full blood count as an ancillary test to support the diagnosis of giant cell arteritis.

Oh LJ, Wong E, Andrici J, et al.

Internal medicine journal 2018; (48(4)):408-413 doi:10.1111/imj.13713.

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.

Dejaco C, Ramiro S, Duftner C, et al.

Annals of the rheumatic diseases 2018; (77(5)):636-643 doi:10.1136/annrheumdis-2017-212649.

Profile of tocilizumab and its potential in the treatment of giant cell arteritis.

Mollan SP, Horsburgh J, Dasgupta B

Eye and brain 2018; (10()):1-11 doi:10.2147/EB.S127812.

Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.

Liozon E, de Boysson H, Dalmay F, et al.

The Journal of rheumatology 2018; (45(5)):678-685 doi:10.3899/jrheum.170455.

Temporal headache and jaw claudication may be the key for the diagnosis of giant cell arteritis.

Peral-Cagigal B, Pérez-Villar Á, Redondo-González LM, et al.

Medicina oral, patologia oral y cirugia bucal 2018; (23(3)):e290-e294 doi:10.4317/medoral.22298.

Bilateral Giant Cell Arteritis Presenting as Bilateral Sudden Vision Loss.

Modi DK, Sheth K, Wade S, et al.

Connecticut medicine 2017; (81(4)):235-236.

Extracranial Giant Cell Arteritis - A Distinctive Subtype.

Nicolescu M, Logee K, Pacheco RA, Mandhadi R

Connecticut medicine 2016; (80(9)):553-557.

Lower ocular pulse amplitude with dynamic contour tonometry is associated with biopsy-proven giant cell arteritis.

Ing E, Pagnoux C, Tyndel F, et al.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2018; (53(3)):215-221 doi:10.1016/j.jcjo.2017.10.027.

Temporal Arteritis Presenting as an Isolated Bilateral Abducens Nerve Palsy: A Rare Case of a 65-year-old Male.

Lunagariya A, Rupareliya C, Bollu PC, Mahuwala Z

Cureus 2018; (10(5)):e2667 doi:10.7759/cureus.2667.

The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis.

Berger CT, Sommer G, Aschwanden M, et al.

Swiss medical weekly 2018; (148()):w14661.

Giant cell arteritis presenting as bilateral anterior ischemic optic neuropathy: a biopsy-proven case report in Chinese patient.

Tian G, Chen W, Chen Q, et al.

BMC ophthalmology 2018; (18(1)):282 doi:10.1186/s12886-018-0953-5.

The role of biologics in the treatment of giant cell arteritis.

González-Gay MA, Pina T, Prieto-Peña D, et al.

Expert opinion on biological therapy 2019; (19(1)):65-72 doi:10.1080/14712598.2019.1556256.

Bilateral Optic Perineuritis as Initial Presentation of Giant Cell Arteritis.

Pappolla A, Silveira F, Norscini J, et al.

The neurologist 2019; (24(1)):26-28 doi:10.1097/NRL.0000000000000206.

Two Cases of Segmental Disc Oedema and Normal Visual Acuity in Giant Cell Arteritis.

Donaldson L, Shemesh AA, Margolin E

Neuro-ophthalmology (Aeolus Press) 2019; (43(3)):201-204 doi:10.1080/01658107.2018.1490778.

[Treatment of giant cell arteritis].

Samson M, Greigert H, Ghesquière T, Bonnotte B

Presse medicale (Paris, France : 1983) 2019; (48(9)):968-979 doi:10.1016/j.lpm.2019.06.002.

[Aortitis in giant cell arteritis: Diagnosis, prognosis and treatment].

Enfrein A, Espitia O, Bonnard G, Agard C

Presse medicale (Paris, France : 1983) 2019; (48(9)):956-967 doi:10.1016/j.lpm.2019.04.018.

[Contribution of Doppler ultrasound for the diagnosis of giant cell arteritis].

Rinagel M, Chatelus E, Arnaud L, Jousse-Joulin S

Presse medicale (Paris, France : 1983) 2019; (48(9)):941-947 doi:10.1016/j.lpm.2019.06.004.

Giant cell arteritis without cranial manifestations caused mesenteric involvement: a case report.

Miyake Y, Morimoto Y, Taniguchi M, et al.

Surgical case reports 2019; (5(1)):119 doi:10.1186/s40792-019-0678-6.

Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.

Lally L, Spiera R

Best practice & research. Clinical rheumatology 2018; (32(6)):803-812 doi:10.1016/j.berh.2019.04.006.

Neuro-Ophthalmologic Complications of Giant Cell Arteritis: Diagnosis and Treatment.

Fein AS, Ko MW

Seminars in neurology 2019; (39(6)):673-681 doi:10.1055/s-0039-1698761.

Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis.

Best JH, Kong AM, Smith DM, et al.

ClinicoEconomics and outcomes research : CEOR 2019; (11()):799-807 doi:10.2147/CEOR.S228400.

Lessons of the month 4: Giant cell arteritis with normal inflammatory markers and isolated oculomotor nerve palsy.

Walters B, Lazic D, Ahmed A, Yiin G

Clinical medicine (London, England) 2020; (20(2)):224-226 doi:10.7861/clinmed.2019-0504.

Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: A case-control study.

Dumont A, Lecannuet A, Boutemy J, et al.

Seminars in arthritis and rheumatism 2020; (50(2)):335-341 doi:10.1016/j.semarthrit.2019.09.008.

[Treatment of giant cell arteritis: what is in the pipeline?]

Holle JU, Moosig F

Zeitschrift fur Rheumatologie 2020; (79(6)):516-522 doi:10.1007/s00393-020-00808-0.

Giant cell arteritis with normal inflammatory markers: case report and review of the literature.

Martins P, Teixeira V, Teixeira FJ, et al.

Clinical rheumatology 2020; (39(10)):3115-3125 doi:10.1007/s10067-020-05116-1.

Scalp Necrosis Revealing Severe Giant-Cell Arteritis.

Idoudi S, Ben Kahla M, Mselmi F, et al.

Case reports in medicine 2020; (2020()):8130404 doi:10.1155/2020/8130404.

Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.

Sharma A, Mohammad AJ, Turesson C

Seminars in arthritis and rheumatism 2020; (50(5)):1040-1048 doi:10.1016/j.semarthrit.2020.07.005.

Current advances in giant cell arteritis.

Kaushik M, Ponte C, Mollan SP

Current opinion in neurology 2021; (34(1)):133-141 doi:10.1097/WCO.0000000000000889.

Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden.

Thomsen H, Li X, Sundquist K, et al.

Scientific reports 2020; (10(1)):20887 doi:10.1038/s41598-020-77857-7.

An interesting case of temporal arteritis that manifested as ptosis and diplopia.

Martis A, Hassan RS, Alburquerque AG, et al.

Oxford medical case reports 2020; (2020(11)):omaa099 doi:10.1093/omcr/omaa099.

Transient Monocular Visual Loss: When Is It an Emergency?

Jeeva-Patel T, Kabanovski A, Margolin E

The Journal of emergency medicine 2021; (60(2)):192-196 doi:10.1016/j.jemermed.2020.10.013.

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations.

Unizony S, McCulley TJ, Spiera R, et al.

Arthritis research & therapy 2021; (23(1)):8 doi:10.1186/s13075-020-02377-8.

Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis.

Baalbaki H, Jalaledin D, Lachance C, et al.

Clinical rheumatology 2021; (40(8)):3207-3217 doi:10.1007/s10067-021-05643-5.

Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.

El Chami S, Springer JM

The Medical clinics of North America 2021; (105(2)):311-324 doi:10.1016/j.mcna.2020.09.014.

Myocardial infarction during giant cell arteritis: A cohort study.

Greigert H, Zeller M, Putot A, et al.

European journal of internal medicine 2021; (89()):30-38 doi:10.1016/j.ejim.2021.02.001.

Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice.

Craig G, Knapp K, Salim B, et al.

Rheumatology and therapy 2021; (8(1)):529-539 doi:10.1007/s40744-021-00290-3.

Corticosteroid Usage in Giant Cell Arteritis.

Kanakamedala A, Hussain M, Kini A, et al.

Neuro-ophthalmology (Aeolus Press) 2021; (45(1)):17-22 doi:10.1080/01658107.2020.1767656.

Giant Cell Arteritis among Fevers of Unknown Origin (FUO): An Atypical Presentation.

Grazioli-Gauthier L, Marcoli N, Vanini G, et al.

European journal of case reports in internal medicine 2021; (8(3)):002254 doi:10.12890/2021_002254.

A French cohort of patients with giant cell arteritis: glucocorticoid treatment and its associated side effects.

Perrineau S, Ghesquière T, Charles P, et al.

Clinical and experimental rheumatology 2021; (39 Suppl 129(2)):155-160 doi:10.55563/clinexprheumatol/0nd4kk.

[Giant Cell Arteritis].

Suzuki F, Kimura K

Brain and nerve = Shinkei kenkyu no shinpo 2021; (73(5)):496-502 doi:10.11477/mf.1416201791.

Treatment failure in giant cell arteritis.

Unizony SH, Bao M, Han J, et al.

Annals of the rheumatic diseases 2021; (80(11)):1467-1474 doi:10.1136/annrheumdis-2021-220347.

Bilateral Vertebral Artery Vasculitis-A Rare Manifestation of Giant Cell Arteritis and a Difficult Diagnosis Made Possible by 2-[18F]FDG PET/CT.

Justesen ND, Hansen MS, Jensen MR, et al.

Diagnostics (Basel, Switzerland) 2021; (11(5)) doi:10.3390/diagnostics11050879.

Arterial-embolic Strokes and Painless Vision Loss Due to Phase II Aortitis and Giant Cell Arteritis: A Case Report.

Endres K, Anjum O, Costain N

Clinical practice and cases in emergency medicine 2021; (5(2)):174-177 doi:10.5811/cpcem.2021.2.51143.

Retinal Detachment and Temporal Artery Dissection: An Elusive Case of Giant Cell Arteritis.

Farrukh H, VandenBerg C, Ertel E, et al.

Cureus 2021; (13(7)):e16703 doi:10.7759/cureus.16703.

Giant cell arteritis: A case report and review of literature.

Crain MA, Lakhani DA, Winkler L, et al.

Radiology case reports 2021; (16(12)):3734-3738 doi:10.1016/j.radcr.2021.08.072.

New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.

Stone JH, Spotswood H, Unizony SH, et al.

Rheumatology (Oxford, England) 2022; (61(7)):2915-2922 doi:10.1093/rheumatology/keab780.

Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment.

Esen I, Jiemy WF, van Sleen Y, et al.

Journal of clinical medicine 2021; (10(21)) doi:10.3390/jcm10214958.

Efficacy of bilateral temporal artery biopsies and sectioning of the entire block of tissue for the diagnosis of temporal arteritis.

Agostino A, Farmer J, Blanco P, et al.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2022; (59()):107425 doi:10.1016/j.carpath.2022.107425.

Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.

El Chami S, Springer JM

Rheumatic diseases clinics of North America 2022; (48(2)):493-506 doi:10.1016/j.rdc.2022.02.007.

Abdominal Pain in a Patient With Giant Cell Arteritis.

Sundararajan T, Chauhan K

Cureus 2022; (14(4)):e24149 doi:10.7759/cureus.24149.

[Large Vessel Vasculitides: Giant Cell Arteritis and Takayasu Arteritis - Similarities and Differences].

Gloor AD, Christ L

Therapeutische Umschau. Revue therapeutique 2022; (79(5)):221-228 doi:10.1024/0040-5930/a001353.

Vasculitogenic T Cells in Large Vessel Vasculitis.

Watanabe R, Hashimoto M

Frontiers in immunology 2022; (13()):923582 doi:10.3389/fimmu.2022.923582.

A nationwide study of ocular manifestations leading to hospital contacts among patients with giant cell arteritis.

Therkildsen P, de Thurah A, Faurschou M, et al.

Seminars in arthritis and rheumatism 2022; (56()):152071 doi:10.1016/j.semarthrit.2022.152071.

An Unusual Case of Giant Cell Arteritis.

Goyal N, Basnet A, Donenfeld TT, et al.

Cureus 2022; (14(7)):e26483 doi:10.7759/cureus.26483.

Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review.

Raleigh MF, Stoddard J, Darrow HJ

American family physician 2022; (106(4)):420-426.

Evolution of ultrasound in giant cell arteritis.

Kirby C, Flood R, Mullan R, et al.

Frontiers in medicine 2022; (9()):981659 doi:10.3389/fmed.2022.981659.

Clinical Diagnosis of Temporal Arteritis With Seronegative and Negative Biopsy Studies.

Bayas A, Carranza O, Swerdloff MA

Cureus 2022; (14(11)):e31011 doi:10.7759/cureus.31011.

Is Erythrocyte Sedimentation Rate Necessary for the Initial Diagnosis of Giant Cell Arteritis?

Hansen MS, Klefter ON, Terslev L, et al.

Life (Basel, Switzerland) 2023; (13(3)) doi:10.3390/life13030693.

Imaging of giant cell arteritis - recent advances.

Owen CE, Yates M, Liew DFL, et al.

Best practice & research. Clinical rheumatology 2023; (37(1)):101827 doi:10.1016/j.berh.2023.101827.

[Epidemiology and pathophysiology of giant cell arteritis].

Greigert H, Bonnotte B, Samson M

La Revue du praticien 2023; (73(4)):380-386.

Giant cell arteritis and innovative treatments.

Costanzo G, Ledda AG, Sambugaro G

Current opinion in allergy and clinical immunology 2023; (23(4)):327-333 doi:10.1097/ACI.0000000000000923.

Arteritic Anterior Ischemic Optic Neuropathy (AAION) Associated with COVID-19 Infection: A Case Report and Review of the Literature.

Shahraki K, Najafi A, Ashoori N, et al.

Case reports in ophthalmological medicine 2023; (2023()):9009925 doi:10.1155/2023/9009925.

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update.

Dejaco C, Ramiro S, Bond M, et al.

Annals of the rheumatic diseases 2024; (83(6)):741-751 doi:10.1136/ard-2023-224543.

Updates on the Prognosis of Giant Cell Arteritis: A Systematic Review.

Abukanna AM, Alanazi YF, Alanazi FWS, et al.

Cureus 2023; (15(12)):e50299 doi:10.7759/cureus.50299.

Orbital MRI Findings in a Patient With Giant Cell Arteritis (GCA): A Case Report.

Alhawiti S, AlSulaim T

Cureus 2023; (15(11)):e49507 doi:10.7759/cureus.49507.

Usefulness of 18F-FDG PET-CT for assessing large-vessel involvement in patients with suspected giant cell arteritis and negative temporal artery biopsy.

Narváez J, Estrada P, Vidal-Montal P, et al.

Arthritis research & therapy 2024; (26(1)):13 doi:10.1186/s13075-023-03254-w.

Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging.

Brittain JM, Hansen MS, Carlsen JF, et al.

Diagnostics (Basel, Switzerland) 2023; (14(1)) doi:10.3390/diagnostics14010081.

Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial.

Stone JH, Han J, Aringer M, et al.

The Lancet. Rheumatology 2021; (3(5)):e328-e336 doi:10.1016/S2665-9913(21)00038-2.

Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis.

Pouncey AL, Yeldham G, Magan T, et al.

The Cochrane database of systematic reviews 2024; (2()):CD013199 doi:10.1002/14651858.CD013199.pub2.

Giant Cell Arteritis: Advances in Understanding Pathogenesis and Implications for Clinical Practice.

Paroli M, Caccavale R, Accapezzato D

Cells 2024; (13(3)) doi:10.3390/cells13030267.

Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand.

van Dantzig P, Quincey V, Kurz J, et al.

The New Zealand medical journal 2024; (137(1592)):14-21 doi:10.26635/6965.6379.

Multimodality imaging to assess diagnosis and evaluate complications of large vesselarteritis.

Aghayev A, Weber B, Lins de Carvalho T, et al.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2024; (37()):101864 doi:10.1016/j.nuclcard.2024.101864.

The utility of 18F-FDG-PET/CT in detecting extracranial large vessel vasculitis in rheumatic polymyalgia or giant cell arteritis. A systematic review and meta-analysis.

González-García A, Fabregate M, Serralta G, et al.

Revista clinica espanola 2024; (224(7)):445-456 doi:10.1016/j.rceng.2024.06.005.

Predictive Factors for Biopsy-Negative Giant Cell Arteritis and Alternative Diagnoses in a Neuro-Ophthalmology Context.

Kwok L, Wu E, Sheth SJ, et al.

Neuro-ophthalmology (Aeolus Press) 2024; (48(4)):267-271 doi:10.1080/01658107.2024.2311131.

Giant Cell Arteritis: Updates and Controversies.

Yu E, Chang JR

Frontiers in ophthalmology 2022; (2()):848861 doi:10.3389/fopht.2022.848861.

Role and potential of 18F-fluorodeoxyglucose-positron emission tomography-computed tomography in large-vessel vasculitis: a comprehensive review.

Collada-Carrasco J, Gómez-León N, Castillo-Morales V, et al.

Frontiers in medicine 2024; (11()):1432865 doi:10.3389/fmed.2024.1432865.

[News on the imaging of large vessel vasculitis].

Schäfer VS, Petzinna SM, Schmidt WA

Zeitschrift fur Rheumatologie 2024; (83(10)):800-811 doi:10.1007/s00393-024-01565-0.

Giant Cell Arteritis: Can Simple Ultrasound Examination Prevent Complex Consequences?

Stańska W, Kruszewski R, Juszkiewicz A, et al.

Diagnostics (Basel, Switzerland) 2024; (14(18)) doi:10.3390/diagnostics14182071.

Atypical Signs and Symptoms of Giant Cell Arteritis: A Systematic Review.

Sverdlichenko I, Xie JS, Lu B, et al.

Journal of general internal medicine 2025; (40(3)):659-665 doi:10.1007/s11606-024-09141-7.

Lingual Necrosis in the Setting of Giant Cell Arteritis.

Balaji N, Ignatowicz A, Khan S, et al.

Cureus 2024; (16(11)):e74316 doi:10.7759/cureus.74316.

Aortic disease in giant cell arteritis.

Warrington KJ

Seminars in arthritis and rheumatism 2025; (72S()):152677 doi:10.1016/j.semarthrit.2025.152677.

Unilateral Central Retinal Artery Occlusion Revealing Giant Cell Arteritis: A Case Report.

Lazaar H, Moumni A, Aziz A, et al.

Cureus 2025; (17(3)):e80452 doi:10.7759/cureus.80452.

Is Giant Cell Arteritis Associated with Increased Risk of Cardiovascular Disease? A Meta-Analysis.

Jain H, Shahzad M, Patel N, et al.

Cardiology in review 2025; doi:10.1097/CRD.0000000000000928.

Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot.

Currier CE, Bays AM, Thomason JL

Rheumatology international 2025; (45(8)):175 doi:10.1007/s00296-025-05930-3.

Predictors of Permanent Vision Loss in Giant Cell Arteritis.

Tucker SM, Haas SJ, Zaihra Rizvi T

Neuro-ophthalmology (Aeolus Press) 2025; (49(1)):60-68 doi:10.1080/01658107.2024.2389934.

Case Report: Transient monocular vision loss with isolated paracentral acute middle maculopathy on optical coherence tomography: beware of giant cell arteritis!

Alencastro Landim G, Bénard-Séguin E, Newman NJ, Biousse V

Frontiers in neurology 2025; (16()):1672043 doi:10.3389/fneur.2025.1672043.

Halo Sign on Temporal Artery Ultrasound Aids in Prompt Diagnosis of Giant Cell Arteritis.

Laszlofy L, Bardoczi A, Husvethova D, et al.

Methodist DeBakey cardiovascular journal 2025; (21(1)):100-105 doi:10.14797/mdcvj.1635.

Clinical Decision-Making Case: A Giant Headache.

Portman M, Herman L

Journal of education & teaching in emergency medicine 2025; (10(5)):CE239-CE259 doi:10.21980/J8.52322.

Prognosis and long term outcome of stenotic large vessel involvement in giant cell arteritis.

Maalouf G, Arnould B, Espitia O, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2026; doi:10.1002/art.70101.

A Diagnostic Headache.

Glynn T, Leech MT, Goergen SK, et al.

The Medical journal of Australia 2026; (224(3)):e70151 doi:10.5694/mja2.70151.

Treatment-Resistant Arterial Hypertension Revealing Giant Cell Arteritis: A Case Report.

Yassir DL, Moudatir PM, Echchilali PK, El Kabli PH

The American journal of medicine 2026; doi:10.1016/j.amjmed.2026.02.015.

Ultrasound, PET/CT or temporal artery biopsy for giant cell arteritis? A prospective diagnostic accuracy study (the GAME-study).

Hansen MS, Terslev L, Døhn UM, et al.

Acta ophthalmologica 2026; doi:10.1111/aos.70114.